Following his graduation from St. Stephen University, Gödöllő, as agricultural engineer and Hungarian-English translator, in 1992, he had worked over ten years in the financial and commodity futures markets. Then, following the turn of the millennium, he had begun his carrier in the private equity and venture capital industry and related businesses. From 2005 through 2010, he had worked as deputy CEO and later (2007-2010) as CEO and Member of the Board at Corvinus Venture Capital Fund Managing Ltd., where he was responsible for managing two venture capital funds, with a total of EUR 70 million in equity. In relation with these positions, he had also participated actively in establishing standard rules and regulations as well as regulated operations of venture capital fund management in Hungary. Since 2010, he has been participating as Member of the Board in the financial and strategic management of a US based, venture capital backed drug-development group. In the meantime, he had also maintained his venture capital fund management activities as senior investment advisor in the teams of Finatech from 2012 to 2014 and X-Ventures from 2016 to 2016, respectively. In addition to that, he had been providing strategic business development consultancy to a clinical research and medical services group, also developing medical devices. In 2018, he rejoined the team of Finatech.